NEW YORK, Dec. 5, 2017 /PRNewswire/ -- Future Market Insights offers 10-year forecast on the global respiratory inhaler devices market between 2017 and 2027. This study covers the market dynamics and ...

PORTLAND, Ore., Nov. 26, 2025 /PRNewswire/ -- Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as asthma and chronic obstructive ...

Global Respiratory Inhalers Market Forecast2021-2031 (Value & Volume): - by Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others ...

GSK plc announced positive phase III data from its clinical programme to develop a next-generation version of its metered dose inhaler (MDI), Ventolin (salbutamol). Data confirm that the formulation ...

New York, March 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Digital Dose Inhaler Market Research Report by Product, by Type - Global Forecast to 2025 - ...

Please provide your email address to receive an email when new articles are posted on . The majority of patients demonstrated improper usage of epinephrine autoinjectors and metered-dose inhalers, ...

Asthma inhalers are critical for delivering small amounts of medication to people's lungs to improve breathing and help prevent asthma attacks, but those tiny puffs add up to a large environmental ...

According to the report, the metered dose inhalers market was valued at $10.1 billion in 2024, and is estimated to reach $18.4 billion by 2034, growing at a CAGR of 6.2% from 2025 to 2034.